Deferiprone (DFP) Targets Cancer Stem Cell (CSC) Propagation by Inhibiting Mitochondrial Metabolism and Inducing ROS Production

Deferiprone (DFP), also known as Ferriprox, is an FDA-approved, orally active, iron chelator that is currently used clinically for the treatment of iron-overload, especially in thalassaemia major. As iron is a critical factor in Fe-S cluster assembly that is absolutely required for the metabolic fun...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cells
Asıl Yazarlar: Fiorillo, Marco, Tóth, Fanni, Brindisi, Matteo, Sotgia, Federica, Lisanti, Michael P.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MDPI 2020
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7349387/
https://ncbi.nlm.nih.gov/pubmed/32585919
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells9061529
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller